Taste Modulator and Method of Use Thereof Geschmacksmodulator Und Verfahren Zur Verwendung Davon Modulateur De Goût Et Son Procédé D’Utilisation

Total Page:16

File Type:pdf, Size:1020Kb

Taste Modulator and Method of Use Thereof Geschmacksmodulator Und Verfahren Zur Verwendung Davon Modulateur De Goût Et Son Procédé D’Utilisation (19) TZZ¥ZZ_T (11) EP 3 005 884 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A23L 27/10 (2016.01) A23L 7/126 (2016.01) 19.04.2017 Bulletin 2017/16 A21D 2/26 (2006.01) A21D 2/36 (2006.01) A23L 2/56 (2006.01) A61Q 11/00 (2006.01) (2017.01) (2006.01) (21) Application number: 15189164.5 A61K 8/97 A61K 36/232 A23L 23/00 (2016.01) (22) Date of filing: 09.10.2015 (54) TASTE MODULATOR AND METHOD OF USE THEREOF GESCHMACKSMODULATOR UND VERFAHREN ZUR VERWENDUNG DAVON MODULATEUR DE GOÛT ET SON PROCÉDÉ D’UTILISATION (84) Designated Contracting States: • JOHN, Thumpalasseril V. AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Morganville, NJ 07751 (US) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • KIM, Jung-A PL PT RO RS SE SI SK SM TR Edgewater, NJ 07020 (US) • SINGH, Ajay Pratap (30) Priority: 10.10.2014 US 201414511963 Highland Park, NJ 08904 (US) (43) Date of publication of application: (74) Representative: Lawrence, John 13.04.2016 Bulletin 2016/15 Barker Brettell LLP 100 Hagley Road (73) Proprietor: International Flavors & Fragrances Inc. Edgbaston New York, NY 10019 (US) Birmingham B16 8QQ (GB) (72) Inventors: (56) References cited: • CHIN, Hsi-Wen EP-A1- 2 641 479 WO-A1-2013/085014 Tinton Falls, NJ 07724 (US) JP-A- 2006 191 826 JP-A- 2007 176 919 JP-B1- 4 606 505 Note: Within nine months of the publication of the mention of the grant of the European patent in the European Patent Bulletin, any person may give notice to the European Patent Office of opposition to that patent, in accordance with the Implementing Regulations. Notice of opposition shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention). EP 3 005 884 B1 Printed by Jouve, 75001 PARIS (FR) EP 3 005 884 B1 Description Background 5 [0001] Health practitioners have been promoting the benefits of whole grain foods. The importance of increasing whole grain consumption is reflected in the changes in recommendations set forth by government and health organization expert groups. In the Healthy People 2010 Report (National Academy Press, 1999), it is recommended that for a 2,000 calorie diet, individuals two years and older should consume at least six daily servings of grain products with at least three being whole grains. In the 2005 Dietary Guidelines for Americans it is recommended that consumers should eat 10 three or more ounce equivalents of whole grain foods each day, with the rest coming from enriched or whole grain flours. In general, at least half of the intake should come from whole grains. The American Heart Association, American Diabetes Association and the American Cancer Society also make specific recommendations regarding increasing the consump- tion of whole grains. [0002] Despite the well-documented nutritional advantages of eating whole grain products as compared to refined 15 flour products, consumers often like refined breads better than whole wheat breads, indicating that sensory properties are a barrier to consumption of whole wheat bread (Bakke & Vickers (2007) J. Food Sci. 72:S473-S480; Moskowitz, et al. (2012) J. Agric. Food Chem. 60:11245-11252). Currently, in the United States, consumption of white bread made from refined wheat flour is greater than that of whole wheat bread. Such consumer preference for refined flour products may limit the use of current whole grain wheat flours in bakery and snack products. 20 [0003] Improving the palatability of whole grain foods would help promote the acceptance and consumption of the healthful whole grain foods by consumers. In this respect, the use of methylsulfonylmethane to reduce bitterness and undesirable flavors in various food products, including grain products, has been suggested. See WO 2010/141889. WO 2013/085014 and JP 2007176919 describe a taste-masking compositions comprising a vegetable extract, including Angelica keiskei. However, there remains a need in the art to develop nutritious, high fiber food products and fiber 25 supplements which have a texture and taste more palatable to a number of consumers. Summary of the Invention [0004] The invention provides a method of reducing an undesirable taste in a product selected from the group consisting 30 of a food product, a dental product, an oral hygiene product and a medicinal product comprising the step of incorporating a taste-masking composition, wherein the taste-masking composition comprises a taste-masking effective amount rang- ing from 1 to 5000 ppm by weight of the composition of an Angelica root extract, and wherein the Angelica root extract is prepared by a process comprising the steps of: (i) submerging a root of an Angelica sinensis in a solvent selected from the group consisting of water, an organic solvent and a mix thereof; (ii) circulating the solvent continuously through 35 the root of the Angelica sinensis at a temperature ranging from room temperature to 100 °C to provide a soluble extract; and (iii) collecting the soluble extract from step (ii) and evaporating the solvent to provide the Angelica root extract. [0005] The present invention relates to a novel taste-masking composition and its unexpected advantageous use in reducing an undesirable taste in a food product ( e.g., a beverage, broth, or whole grain food product), a dental product, an oral hygiene product or a medicinal product. Specifically, the present invention relates to the taste-masking composition 40 comprising a taste-masking effective amount of an Angelica sinensis. extract. [0006] The present invention also relates to the surprising finding of the unexpected effectiveness of the taste-masking composition provided above in reducing an undesirable taste in a food product ( e.g., a beverage, broth, or whole grain food product), a dental product, an oral hygiene product or a medicinal product. [0007] The present invention further relates to a method of reducing an undesirable taste in a food product, a dental 45 product, an oral hygiene product or a medicinal product through the incorporation of the taste-masking composition provided above. [0008] These and other embodiments of the present invention will be apparent by reading the following specification. Brief Description of the Drawings 50 [0009] Figure 1 shows the flavor profile of a wheat cracker containing an extract of Angelica sinensis root. N=11. * Directional difference at p=0.10. ** Significant difference between the two samples at p=0.05. 55 Figure 2 shows the number of samples preferred in a paired comparison test between a basic wheat cracker and a wheat cracker treated with Angelica root extract. N=22. 2 EP 3 005 884 B1 Detailed Description of the Invention [0010] An extract of Angelica root is known for its medicinal use. It also has the organoleptic characteristics of herba- ceous, celery, hay, grainy, woody, bitter, dried and cardboard and is therefore used in perfumery and flavoring. It has 5 now been surprisingly found that at a taste-masking effective amount theAngelica sinensis root extract is effective in masking the off-flavors associated with various products and, in particular, food products such as whole grain foods. Specifically, water and/or organic solvent extracts of root samples of A. sinensis and A. archangelica improve the taste of whole grain foods by reducing bitter and astringent tastes and the harsh mouthfeel of whole grain products such as bread, crackers and pasta. In addition, Angelica root extracts were found to reduce bitter, metallic, astringent, and off- 10 taste/linger of beverages and broths. Therefore, the present invention provides a method for reducing an undesirable taste of various products such as food products by adding an Angelica sinensis root extract as described herein. [0011] Angelica sinensis, also known as Dong Quai, is perennial herb used in traditional Chinese herbal medicine. A. sinensis contains a number of compounds including, but not limited to vitamin B12, vitamin E, carotene, pantothenic acid, folic acid, folinic acid, biotin, nicotinic acid, nicotinamide, sucrose, butylidene phthalide, n-valerophenone-o-car- 15 boxylic acid dehydrophthalic anhydride, beta-sitosterol, sitosterol-D-glucoside, monoterpene hydrocarbons, monoter- pene alcohols, oxygenated sesquiterpenes, ethyl ethers of monoterpene alcohols, ethyl sterols of long chain fatty acids, falcarinol, falcarindiol, falcarinolone, choline, scopoletin, archangelicin, 8(S),9(R)-9-angeloyl-oxy-8,9-dihydrooroselol, psoralen, bergapten, xanthotoxin, chalcones such as asitaba-chalcone, 4-hydroxyderricin, water soluble tannin,α- pinene, myrcene, p-cymene, oxypeucedanin, imperatorin, isoimeratorin, ferulic acid, columbianetin, columbianetin ac- 20 etate, columbiadin, osthol, isoimperatorin, columbianetin-β-D-glucopyranoside, and AR-4E-2, 1, safrole, isosafrole, n- dodecanol, n-tetradecanol, palmitic acid. See, Monograph Angelica sinensis (2004) Alter. Med. Rev. 9:429-433; Noé (1998) J. Naturopathic Med. 7:66-72. In addition, A. sinensis contains alkyl phthalides such as ligustilide, (Z)-ligustilide, (Z)-6,7-epoxyligustilide, angelicide, (Z)-butylidene phthalide, butyl-phthalide, and 2,4-dihydrophthalic anhydride, which are the major components of the essential oil fraction of the roots. The non-volatile constituents reported are phenylpro- 25 panoids ((E)-ferulic acid coniferyl ferulate); benzenoids (valerophenone-o-carboxylic acid and vanillic acid); and cou- marins (angelol G, angelicone and umbelliferone. See, WHO Monographs on Selected Medicinal Plants (2004) Vol. 2, pages 25-34. Other known components found in the root ofA. sinensis include, but are not limited to, alanine,α - tocopherol, angelic acid, Angelica polymorpha alkaloid, Angelica polysaccharide-AS-1, compound E-232, angelicone, angelol, arachidonic acid, brefeldin A, cadinene, carvacrol, choline, dodecan-1-ol, GABA, gamma-aminobutyric acid, 30 lignoceric acid, n-tetradecane, n-valerophenone-o-carbonic acid, and neoangelide. See, Dr. Duke’s Phytochemical and Ethnobotanical Databases provided by the Agricultural Research Service, Germplasm Resources Information Network.
Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2008/008994.6 A1 Olalde Rangel (43) Pub
    US 2008.00899.46A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/008994.6 A1 Olalde Rangel (43) Pub. Date: Apr. 17, 2008 (54) SYNERGISTIC PHYTOCEUTICAL A6IR 36/21 (2006.01) COMPOSITIONS A6IR 36/232 (2006.01) A6IR 36/258 (2006.01) (76) Inventor: Jose Angel Olalde Rangel, Caracas A6IR 36/28 (2006.01) (VE) A6IR 36/286 (2006.01) A6IR 36/3 (2006.01) Correspondence Address: A6IR 36/4I (2006.01) BAKER & MCKENZE LLP A6IR 36/45 (2006.01) Pennzoil Place, South Tower A6IR 36/48 (2006.01) 711 Louisiana, Suite 3400 A6IR 36/7 (2006.01) HOUSTON, TX 77002-2716 (US) A6IP 7/00 (2006.01) A6IP 5/00 (2006.01) (21) Appl. No.: 11/924,122 A6IP 9/00 (2006.01) (52) U.S. Cl. .................... 424/548; 424/195.15; 424/725: (22) Filed: Oct. 25, 2007 424/726; 424/728; 424/732: 424/737; 424/752; 424/755; Related U.S. Application Data 424/757; 424/773; 424/775 (62) Division of application No. 1 1/271,940, filed on Nov. (57) ABSTRACT 10, 2005, now Pat. No. 7,303,772. Phytoceutical compositions for the prevention and treatment Publication Classification of circulatory disorders, feminine endocrine disorders, and dermal disorders. A specific combination of extracts of (51) Int. Cl. plants is taught, as well as principles for varying the for A6 IK 36/00 (2006.01) mulations based on categorizing plants into one of three A6 IK 35/32 (2006.01) groups, Energy, Bio-Intelligence, and Organization and A6 IK 36/074 (2006.01) selecting several plants from each group.
    [Show full text]
  • Division of Pharmaceutical Biology Faculty of Pharmacy University of Helsinki
    Division of Pharmaceutical Biology Faculty of Pharmacy University of Helsinki Plant secondary metabolites in Peucedanum palustre and Angelica archangelica and their plant cell cultures Manu Juho Mikael Eeva ACADEMIC DISSERTATION To be presented with the permission of the Faculty of Pharmacy of the University of Helsinki, for public criticism in Auditorium LS.2 (A109) (Latokartanonkaari 7 – Building B) on May 21th, 2010, at 12 o´clock noon. HELSINKI 2010 Supervisors Prof. Heikki Vuorela Ph. D. (Pharm.) Division of Pharmaceutical Biology Faculty of Pharmacy, University of Helsinki, Finland Prof. Pia Vuorela Ph. D. (Pharm.) Pharmaceutical Sciences Åbo Akademi University, Turku, Finland Prof. Raimo Hiltunen Ph. D. (Pharm.) Division of Pharmaceutical Biology Faculty of Pharmacy, University of Helsinki, Finland Reviewers Prof. Riitta Julkunen-Tiitto Ph. D. Department of Biology University of Eastern Finland, Finland Prof. Juha-Pekka Salminen Ph. D. Department of Chemistry University of Turku, Finland Opponent Prof. Elín Soffía Ólafsdóttir Ph. D. (Pharm.) Faculty of Pharmacetical Sciences School of Health Sciences University of Iceland, Iceland ISBN: 978-952-10-6186-8 (paperback) ISSN 1795-7079 ISBN 978-952-10-6187-5 (PDF) http://ethesis.helsinki.fi/ Yliopistopaino, Helsinki 2010 CONTENTS 1 ACKNOWLEDGEMENTS 5 2 ABSTRACT 7 3 LIST OF ORIGINAL PUBLICATIONS 8 4 ABBREVIATIONS 9 5 INTRODUCTION 10 6 REVIEW OF THE LITERATURE 12 6.1 Botany and distribution of A. archangelica and P. palustre 12 6.2 Ethnobotany of A. archangelica and P. palustre 14 6.3
    [Show full text]
  • Assessment Report on Levisticum Officinale Koch, Radix Based on Article 16D(1), Article 16F and Article 16H of Directive 2001/83/EC As Amended (Traditional Use)
    27 March 2012 EMA/HMPC/524623/2011 Committee on Herbal Medicinal Products (HMPC) Assessment report on Levisticum officinale Koch, radix Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC as amended (traditional use) Draft Herbal substance(s) (binomial scientific name of Levisticum officinale Koch, radix the plant, including plant part) Lovage root Herbal preparation(s) Comminuted herbal substance Pharmaceutical forms Comminuted herbal substance as herbal tea for oral use Rapporteur Assessor(s) Note: This Assessment Report is published to support the release for public consultation of the draft Community herbal monograph on Levisticum officinale Koch, radix. It should be noted that this document is a working document, not yet fully edited, and which shall be further developed after the release for consultation of the monograph. Interested parties are welcome to submit comments to the HMPC secretariat, which the Rapporteur and the MLWP will take into consideration but no ‘overview of comments received during the public consultation’ will be prepared in relation to the comments that will be received on this assessment report. The publication of this draft assessment report has been agreed to facilitate the understanding by Interested Parties of the assessment that has been carried out so far and led to the preparation of the draft monograph. 7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7051 E -mail [email protected] Website www.ema.europa.eu An agency of the European Union © European Medicines Agency, 2012. Reproduction is authorised provided the source is acknowledged.
    [Show full text]
  • Approche Métabolomique Pour Une Caractérisation Plus Fine D'extraits De Plantes D'intérêts Pour La Santé Humaine
    Approche métabolomique pour une caractérisation plus fine d’extraits de plantes d’intérêts pour la santé humaine Julien Delecolle To cite this version: Julien Delecolle. Approche métabolomique pour une caractérisation plus fine d’extraits de plantes d’intérêts pour la santé humaine. Biologie végétale. Université de Strasbourg, 2017. Français. NNT : 2017STRAJ012. tel-01559676 HAL Id: tel-01559676 https://tel.archives-ouvertes.fr/tel-01559676 Submitted on 10 Jul 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Thèse de doctorat de l’Université de Strasbourg Ecole doctorale des Sciences de la Vie et de la Santé (ED 414) Discipline : Sciences de la vie, biologie, biochimie UPR 2357 Institut de Biologie Moléculaire des Plantes Approche métabolomique pour une caractérisation plus fine dextraits de plantes dintérêts pour la santé humaine Présentée par Julien DELECOLLE Pour obtenir le grade de Docteur de l’Université de Strasbourg Soutenance le 03 mars 2017 Membres de la commission dexamen Pr. Raphaël DUVAL Rapporteur externe Pr. Alain HEHN Rapporteur externe Dr. Christine SCHAEFFER-REISS Examinateur interne Dr. Dimitri HEINTZ Directeur de thèse Table des matières INTRODUCTION 1 I. Contexte de la thèse 1 II.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases Chemicals Found in Angelica Archangelica
    Dr. Duke's Phytochemical and Ethnobotanical Databases Chemicals found in Angelica archangelica Activities Count Chemical Plant Part Low PPM High PPM StdDev Refernce Citation 0 (+)-ALPHA-COPAENE Seed Essent. Oil -- 0 (+)-ALPHA-CURCUMENE Root Essent. Oil -- 0 (+)-CUPARENE Root -- 0 (+)-LIMONENE Root -- 0 (+)-OXYPEUCEDANIN Root -- 0 1,1-DIETHOXYHEXANE Root -- 0 1,1-DIETHOXYHEXANE Root Essent. Oil -- 0 1,1-DIETHOXYOCTANE Root -- 0 1,1-DIETHOXYOCTANE Root Essent. Oil -- 0 1,8-CINEOL Fruit Essent. Oil 538000.0 1.0 -- 0 1-O-BETA-D- Plant Pakistan Encyclopedia Planta GLUCOPYRANOSYL- Medica. 1986. (2S,3P)-3-HYDROXY- MARMESINE 0 12-METHYL-13- Root 1.0 12.0 -- TRIDECANOLIDE 0 12-METHYL-OMEGA- Root Essent. Oil -- TRIDECANOLIDE 0 12-METHYL-OMEGA- Root -- TRIDECANOLIDE 0 13-TRIDECANOLIDE Root 15.0 50.0 -- 0 15- Root Wealth of India. HYDROXYPENTADECANOI C-ACID 0 15-PENTADECANOLIDE Root 15.0 75.0 -- 0 17-HEPTADECANOLIDE Root 2.0 20.0 -- 1 2'-ANGELOYL-3'- Root Phytochem. Anal. 3(1):42-48. ISOVALERYL-VAGINATE 1992 0 2'-BETA-D- Plant Pakistan Encyclopedia Planta GLUCOPYRANOSYLOXY- Medica. 1986. MARMESINE 0 2-DECANONE Root Lawrence, B.M., Essential Oils 1976-1977, Essential Oils 1978, Essential Oils 1979-1980. 0 2-NITRO-1,5-P- Plant J.S. Glasby Dict.Pls MENTHADIENE Containing 2ndary Metabolite. 1991. Activities Count Chemical Plant Part Low PPM High PPM StdDev Refernce Citation 2 2-NONANONE Root 1.0 -- 0 2-PENTYL-FURAN Root 0.0 4.0 1.0 -- 0 4,4,6- Root -- TRIMETHYLCYCLOHEX-2- EN-1-ONE 0 4-ETHOXY-1-P-MENTHENE Root 3.0 -- 0 4-METHOXY-7- Seed Leung, A.
    [Show full text]
  • Assessment Report on Levisticum Officinale Koch, Radix
    20 November 2012 EMA/HMPC/524623/2011 Committee on Herbal Medicinal Products (HMPC) Assessment report on Levisticum officinale Koch, radix Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC as amended (traditional use) Final Herbal substance(s) (binomial scientific name of Levisticum officinale Koch, radix the plant, including plant part) Herbal preparation(s) Comminuted herbal substance Pharmaceutical forms Comminuted herbal substance as herbal tea for oral use Rapporteur Ewa Widy Tyszkiewicz Assessor(s) Ewa Widy Tyszkiewicz 7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7051 E -mail [email protected] Website www.ema.europa.eu An agency of the European Union © European Medicines Agency, 2013. Reproduction is authorised provided the source is acknowledged. Table of contents Table of contents ................................................................................................................... 2 1. Introduction ....................................................................................................................... 3 1.1. Description of the herbal substance(s), herbal preparation(s) or combinations thereof .. 3 1.2. Information about products on the market in the Member States ............................... 5 1.3. Search and assessment methodology ..................................................................... 6 2. Historical data on medicinal use .......................................................................................
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2011/0052718A1 Rangel (43) Pub
    US 2011 0052718A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0052718A1 Rangel (43) Pub. Date: Mar. 3, 2011 (54) SYNERGISTIC PHYTOCEUTICAL A6IR 36/4I (2006.01) COMPOSITIONS A636/7 (2006.01) A636/74 (2006.01) (76) Inventor: José Angel Olalde Rangel, Caracas A636/734 (2006.01) (VE) A6IR 36/45 (2006.01) A6II 35/32 (2006.01) (21) Appl. No.: 12/942,766 A6IP 9/00 (2006.01) A6IP5/00 (2006.01) (22) Filed: Nov. 9, 2010 A6IP 700 (2006.01) Related U.S. Application Data (52) U.S. Cl. .................................... 424/549; 424/195.15 (60) Division of application No. 1 1/271,940, filed on Nov. (57) ABSTRACT 10, 2005, now Pat. No. 7,303,772, Continuation of Phytoceutical compositions for the prevention and treatment application No. 12/705,525, filed on Feb. 12, 2010. of circulatory disorders, feminine endocrine disorders, and O O dermal disorders. A specific combination of extracts of plants Publication Classification is taught, as well as principles for varying the formulations (51) Int. Cl. based on categorizing plants into one of three groups, Energy, A6 IK 36/074 (2006.01) Bio-Intelligence, and Organization and selecting several A6 IK 36/258 (2006.01) plants from each group. Such combinations have synergistic A6 IK 36/28 (2006.01) effects, with minimal side effects. riographic eficience afiabetic rati remissists, irreiraig fest of treatast aetgees hairs. appier trasound se Patent Application Publication Mar. 3, 2011 Sheet 1 of 3 US 2011/0052718A1 fisiae : yesigraisie eitiece 3 filiateig cit reasissists, it airig eigth of treatifier eater ghatas.
    [Show full text]
  • Reflection Paper on Risk Associated with the Use of Herbals Containing
    European Medicines Agency Post-authorisation Evaluation of Medicines for Human Use London, 31 October 2007 Doc. Ref. EMEA/HMPC/317913/2006 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL REFLECTION PAPER ON THE RISKS ASSOCIATED WITH FUROCOUMARINS CONTAINED IN PREPARATIONS OF ANGELICA ARCHANGELICA L. DRAFT AGREED BY THE HMPC October 2006 ADOPTION BY HMPC FOR RELEASE FOR CONSULTATION 11 January 2007 END OF CONSULTATION (DEADLINE FOR COMMENTS) 15 May 2007 ADOPTION BY HMPC 31 October 2007 KEYWORDS HMPC, herbal medicinal products, Angelica archangelica L., furocoumarins, phototoxicity 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 84 00 Fax (44-20) 75 23 70 51 E-mail: [email protected] http://www.emea.europa.eu ©EMEA 2007 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged DRAFT REFLECTION PAPER ON THE RISKS ASSOCIATED WITH FUROCOUMARINS CONTAINED IN PREPARATION OF ANGELICA ARCHANGELICA L. TABLE OF CONTENTS 1. INTRODUCTION (BACKGROUND) ........................................................................................ 3 2. SAFETY EVALUATION OF FUROCOUMARINS (CAS NUMBER 66-97-7) ..................... 3 2.1 PHOTOTOXICITY OF FUROCOUMARINS .................................................................................... 3 2.2 CARCINOGENIC POTENTIAL OF FUROCOUMARINS ................................................................... 4 2.3 MECHANISM OF ACTION .........................................................................................................
    [Show full text]
  • Botanical Name Family Synonym Part Traditionally Used/Specific
    Botanical name Family Synonym Part Part of chemical Info Comments Notes References traditionally concern used/specific preparations Abies alba Mill. Pinaceae bark, branch, Branches: essential Toxicity due to beta-phellandrene beta-phellandrene Yang, S. A., Jeon, S. K., needle, oil (0.2%-0.5%): should be stated. Pure EO should not content should not Lee, E. J., Im, N. K., Jhee, seed, resin bornyl acetate be consumed directly (<0.02 ml of exceed 100 ppm K. H., Lee, S. P., & Lee, I. (30.31%), EO). Content should be stated. (0.01%) daily. S. (2009). Radical camphene scavenging activity of (19.81%), 3-carene the essential oil of silver (13.85%), fir (Abies alba). Journal tricyclene of clinical biochemistry (12.90%), dl- and nutrition, 44(3), 253.; limonene (7.50%), Luebke, W. (2011). beta- α-pinene (2.87%), phellandrene 555-10-2. caryophyllene (2.18%), β- phellandrene (2.13%), borneol (1.74%), bicyclo[2.2.1]hept- 2-ene,2,3-dimethyl (1.64%) and α- terpinene (1.24%) Abies balsamea Pinaceae bark, needle, Essential oil needle Toxicity due to beta-pinene should beta-pinene Pichette, A., Larouche, (L.) Mill. resin, twig; twig (0.6%-1.4%): be stated. Pure EO should not be content should not P. L., Lebrun, M., & essential oil e.g. beta pinene consumed directly (<0.03 ml of EO). exceed 100 ppm Legault, J. (2006). (24%-35%), alpha Content should be stated. (0.01%) daily. Composition and pinene ((6%-11%), antibacterial activity of camphen ((6%- Abies balsamea 11%), . Resin: essential oil. contains 16%-27% Phytotherapy Research, essential oil.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases Chemicals Found in Angelica Archangelica
    Dr. Duke's Phytochemical and Ethnobotanical Databases Chemicals found in Angelica archangelica Activities Count Chemical Plant Part Low PPM High PPM StdDev Refernce Citation 0 (+)-ALPHA-COPAENE Seed Essent. Oil -- 0 (+)-ALPHA-CURCUMENE Root Essent. Oil -- 0 (+)-CUPARENE Root -- 0 (+)-LIMONENE Root -- 0 (+)-OXYPEUCEDANIN Root -- 0 1,1-DIETHOXYHEXANE Root -- 0 1,1-DIETHOXYHEXANE Root Essent. Oil -- 0 1,1-DIETHOXYOCTANE Root Essent. Oil -- 0 1,1-DIETHOXYOCTANE Root -- 0 1,8-CINEOL Fruit Essent. Oil 538000.0 1.0 -- 0 1-O-BETA-D- Plant Pakistan Encyclopedia Planta GLUCOPYRANOSYL- Medica. 1986. (2S,3P)-3-HYDROXY- MARMESINE 0 12-METHYL-13- Root 1.0 12.0 -- TRIDECANOLIDE 0 12-METHYL-OMEGA- Root Essent. Oil -- TRIDECANOLIDE 0 12-METHYL-OMEGA- Root -- TRIDECANOLIDE 0 13-TRIDECANOLIDE Root 15.0 50.0 -- 0 15- Root Wealth of India. HYDROXYPENTADECANOI C-ACID 0 15-PENTADECANOLIDE Root 15.0 75.0 -- 0 17-HEPTADECANOLIDE Root 2.0 20.0 -- 1 2'-ANGELOYL-3'- Root Phytochem. Anal. 3(1):42-48. ISOVALERYL-VAGINATE 1992 0 2'-BETA-D- Plant Pakistan Encyclopedia Planta GLUCOPYRANOSYLOXY- Medica. 1986. MARMESINE 0 2-DECANONE Root Lawrence, B.M., Essential Oils 1976-1977, Essential Oils 1978, Essential Oils 1979-1980. 0 2-NITRO-1,5-P- Plant J.S. Glasby Dict.Pls MENTHADIENE Containing 2ndary Metabolite. 1991. Activities Count Chemical Plant Part Low PPM High PPM StdDev Refernce Citation 2 2-NONANONE Root 1.0 -- 0 2-PENTYL-FURAN Root 0.0 4.0 1.0 -- 0 4,4,6- Root -- TRIMETHYLCYCLOHEX-2- EN-1-ONE 0 4-ETHOXY-1-P-MENTHENE Root 3.0 -- 0 4-METHOXY-7- Seed Leung, A.
    [Show full text]
  • Botanical Name Family Synonym Part Traditionally Used/Specific
    Botanical name Family Synonym Part traditionally Part of chemical Info particular Present in used/specific concern considerations x preparations countries Abelmoschus esculentus (L.) Malvaceae fruit Food (Okra) OK 1 Moench Abelmoschus moschatus Malvaceae seed Essential oil: pyrazine and pyridine derivatives. Young leaves and OK 1 Medik. shoots are eaten Abies alba Mill. Pinaceae bark, branch, Branches: essential oil (0.2%-0.5%): bornyl acetate (30.31%), OK 3 needle, seed, resin camphene (19.81%), 3-carene (13.85%), tricyclene (12.90%), dl- limonene (7.50%), α-pinene (2.87%), caryophyllene (2.18%), β- phellandrene (2.13%), borneol (1.74%), bicyclo[2.2.1]hept-2-ene,2,3- dimethyl (1.64%) and α-terpinene (1.24%) Abies balsamea (L.) Mill. Pinaceae bark, needle, resin, Essential oil needle twig (0.6%-1.4%): e.g. beta pinene (24%-35%), OK 3 twig; essential oil alpha pinene ((6%-11%), camphen ((6%-11%), . Resin: contains 16%- 27% essential oil. Sesquiterpene derivatives: e.g. bisabolene. Resin acids: e.g. canadinol acids Abies nordmanniana subsp. Pinaceae Abies pectinata bark, branch, needle Bark : tannins 10%. Essential oil in needles, branches, bark and resin: OK 1 equi-trojani (Asch. & Sint. ex Dc. Var. Equi- 0.24-0.35%. Sometimes used as falsification for Abies alba Boiss.) Coode & Cullen Trojani Asch. & Sint. Ex Boiss Abies sibirica Ledeb. Pinaceae bark, branch, Needle: essential oil (1.3%-2%): e.g. bornylacetate ( 20%-40%), OK 3 needle, seed, resin camphene (10%-26%), alpha pinene (8%-20%), beta pinene (3%-13%) Botanical name Family Synonym Part traditionally Part of chemical Info particular Present in used/specific concern considerations x preparations countries Abroma augusta L.
    [Show full text]
  • Four Coumarins from Heracleum Yunngningense
    June 2005 Notes Chem. Pharm. Bull. 53(6) 701—704 (2005) 701 Four Coumarins from Heracleum yunngningense a a a b ,a Masahiko TANIGUCHI, Osamu YOKOTA, Makio SHIBANO, Nian-He WANG, and Kimiye BABA* a Osaka University of Pharmaceutical Sciences; 4–20–1 Nasahara, Takatsuki, Osaka 569–1094, Japan: and b Institute of Botany, Jiangsu Province and Academia Sinica; 210014, Nanjing, China. Received January 13, 2005; accepted March 1, 2005 Four new coumarins (1—4) were isolated from the roots of Heracleum yunngningense HAND.–MASS. Their structures were established by spectral analyses. Key words Heracleum yunngningense; Umbelliferae; coumarin The roots of Heracleum yunngningense HAND.–MASS., “永 Compound 1, colorless needles, mp 158—160 °C, was as- ϩ 寧独活”, is a Chinese folk medicine used as an antipyretic, signed the molecular formula C12H10O6 ([M] m/z 250.0465) analgesic, and diaphoretic agent in local areas of Yunnan by high resolution electron impact (HR-EI)-MS. The UV province, China.1,2) In the course of our studies of the chemi- spectrum showed absorption maxima at 293.7, 216.2 and cal constituents of Umbelliferous plants, we have isolated 206.6 nm and IR spectrum absorption bands at 2963, 1731, four new coumarins, yunngnin A (1), yunngnin B (2), yunng- 1648, 1594, 1475 and 1424 cmϪ1, suggesting the presence of noside A (3), and yunngnoside B (4), in addition to a poly- an aromatic ring, an unsaturated lactone and hydroxyl acetylen, falcarindiol, two phenylpropanoids, ferulic acid, p- groups. The 1H- and 13C-NMR spectra (Table 1) of 1 showed
    [Show full text]